Portfolio management articles from across Nature Portfolio

Larger drug companies attempt to ensure consistent financial performance by managing a portfolio of products at different stages of development, from preclinical studies through to marketed products. Generally, only marketed products are bringing in revenue, and they will eventually lose patent protection and revenue from them will drop substantially, and so there is a need to develop new marketed products to maintain overall revenue, but these have a risk of failure in development to account for.